Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5AP | P20292 | 16/20 | 0.39 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.39 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.38 |
| ▸ | CTSA | P10619 | 1/20 | 0.36 |
| ▸ | PPARD | Q03181 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23441545 | 0.90 | ALOX5AP (0.42) | ALOX5APFFAR4CTSAPPARD | |
| SCHEMBL23441547 | 0.90 | ALOX5AP (0.42) | ALOX5APFFAR4CTSAPPARD | |
| SCHEMBL29318141 | 0.89 | HTR2C (0.35) | ALOX5APPTGER4CTSAPPARD | |
| SCHEMBL29318155 | 0.86 | CA1 (0.40) | FFAR4CTSA | |
| SCHEMBL29318409 | 0.84 | GABRG2 (0.39) | FFAR4PTGER4 | |
| SCHEMBL29318130 | 0.81 | PTGS2 (0.42) | ALOX5APFFAR4PTGER4 | |
| SCHEMBL23441567 | 0.78 | FFAR4 (0.53) | ALOX5APFFAR4CTSA | |
| SCHEMBL23441566 | 0.78 | FFAR4 (0.53) | ALOX5APFFAR4CTSA | |
| SCHEMBL23441592 | 0.76 | FFAR4 (0.48) | ALOX5APFFAR4CTSAPPARD | |
| SCHEMBL23441591 | 0.76 | FFAR4 (0.48) | ALOX5APFFAR4CTSAPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240239756-A1 | NOVEL 3, 5-DISUBSTITUTED PYRIDINE AND 3, 5-DISUBSTITUTED PYRIDAZINE DERIVATIVES AND PHARMACEUTICAL USE OF SAME | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2024-07-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240239756-A1 | NOVEL 3, 5-DISUBSTITUTED PYRIDINE AND 3, 5-DISUBSTITUTED PYRIDAZINE DERIVATIVES AND PHARMACEUTICAL USE OF SAME | ENPP2, SSB, PLPBP | ALOX5AP 267/4885FFAR4 1677/4885PTGER4 2402/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.